The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Engineering Macrophage Exosome Disguised Biodegradable Nanoplatform for Enhanced Sonodynamic Therapy of Glioblastoma
Abstract
Sonodynamic therapy (SDT) exhibits high tissue penetration and negligible radiation damage to normal tissues, and thus emerges as a promising cancer therapeutic modality for glioblastoma (GBM). However, the blood−brain barrier (BBB) and hypoxic microenvironment greatly limit the SDT efficiency. In this work, a biodegradable nanoplatform (termed as CSI) is fabricated by encapsulating catalase (CAT) into silica nanoparticles (CAT@SiO 2) for tumor hypoxia relief, and then loaded with the sonosensitizer indocyanine green (ICG). Inspired by the ability of macrophages to cross the BBB, CSI is further coated with AS1411 aptamer‐modified macrophage exosomes to form CSI@Ex‐A, which possesses efficient BBB penetration and good cancer‐cell‐targeting capability. After tumor cell endocytosis, highly expressed glutathione (GSH) triggeres biodegradation of the nanoplatform and the released CAT catalyzes hydrogen peroxide (H 2 O 2) to produce O 2 to relieve tumor hypoxia. The GSH depletion and O 2 self‐supplying effectively enhances the SDT efficiency both in vitro and in vivo. In addition, the resulting CSI@Ex‐A exhibits good biocompatibility and long circulation time. These findings demonstrate that CSI@Ex‐A may serve as a competent nanoplatform for GBM therapy, with potential for clinical translation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Glioblastoma and Other Malignant Gliomas: A Clinical Review
Omuro, A. (2013) · JAMA · doi:10.1001/jama.2013.280319 · Cited by 2,301
Hypoxia, HIF1 and glucose metabolism in the solid tumour
Denko, N. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2468 · Cited by 1,707
Innovative Strategies for Hypoxic‐Tumor Photodynamic Therapy
Li, X., Kwon, N., Guo, T., Liu, Z., & Yoon, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805138 · Cited by 1,175
Self-citationMultifunctional sonosensitizers in sonodynamic cancer therapy
Son, S., Kim, J. H., Wang, X., Zhang, C., Yoon, S. A., Shin, J., Sharma, A., Lee, M. H., Cheng, L., Wu, J., et al. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00648f · Cited by 1,150
Brown, T. J., Brennan, M. C., Li, M., Church, E. W., Brandmeir, N. J., Rakszawski, K. L., Patel, A. S., Rizk, E. B., Suki, D., Sawaya, R., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1373 · Cited by 1,081
Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Huse, J. T., & Holland, E. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2818 · Cited by 763
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Weller, M., van den Bent, M., Hopkins, K., Tonn, J. C., Stupp, R., Falini, A., Cohen-Jonathan-Moyal, E., Frappaz, D., Henriksson, R., Balana, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70011-7 · Cited by 750
Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation
Yang, Z., Shi, J., Xie, J., Wang, Y., Sun, J., Liu, T., Zhao, Y., Zhao, X., Wang, X., Ma, Y., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0485-1 · Cited by 744
Brain immunology and immunotherapy in brain tumours
Sampson, J. H., Gunn, M. D., Fecci, P. E., & Ashley, D. M. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0224-7 · Cited by 722
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Yi, H.-G., Jeong, Y. H., Kim, Y., Choi, Y.-J., Moon, H. E., Park, S. H., Kang, K. S., Bae, M., Jang, J., Youn, H., et al. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0363-x · Cited by 634
Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain
Yuan, D., Zhao, Y., Banks, W. A., Bullock, K. M., Haney, M., Batrakova, E., & Kabanov, A. V. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.011 · Cited by 607
Emerging blood–brain-barrier-crossing nanotechnology for brain cancer theranostics
Tang, W., Fan, W., Lau, J., Deng, L., Shen, Z., & Chen, X. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00805a · Cited by 605
Ultrafine Titanium Monoxide (TiO1+x) Nanorods for Enhanced Sonodynamic Therapy
Wang, X., Zhong, X., Bai, L., Xu, J., Gong, F., Dong, Z., Yang, Z., Zeng, Z., Liu, Z., & Cheng, L. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b10228 · Cited by 532
Self-citationUltrasound‐Activated Sensitizers and Applications
Lin, X., Song, J., Chen, X., & Yang, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201906823 · Cited by 501
Advanced biotechnology-assisted precise sonodynamic therapy
Zhang, Y., Zhang, X., Yang, H., Yu, L., Xu, Y., Sharma, A., Yin, P., Li, X., Kim, J. S., & Sun, Y. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00403d · Cited by 498
Exosome Biochemistry and Advanced Nanotechnology for Next‐Generation Theranostic Platforms
Yang, B., Chen, Y., & Shi, J. (2019) · Advanced Materials · doi:10.1002/adma.201802896 · Cited by 435
Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy
Meijer, T. W. H., Kaanders, J. H. A. M., Span, P. N., & Bussink, J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0858 · Cited by 433
Guo, B., Sheng, Z., Hu, D., Liu, C., Zheng, H., & Liu, B. (2018) · Advanced Materials · doi:10.1002/adma.201802591 · Cited by 431
Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges
Syn, N. L., Wang, L., Chow, E. K.-H., Lim, C. T., & Goh, B.-C. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2017.03.004 · Cited by 399
Song, G., Chen, Y., Liang, C., Yi, X., Liu, J., Sun, X., Shen, S., Yang, K., & Liu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201602111 · Cited by 394
Self-citationCatalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor
Phua, S. Z. F., Yang, G., Lim, W. Q., Verma, A., Chen, H., Thanabalu, T., & Zhao, Y. (2019) · ACS Nano · doi:10.1021/acsnano.9b01087 · Cited by 375
Nanocarrier-based drug combination therapy for glioblastoma
Zhao, M., van Straten, D., Broekman, M. L. D., Préat, V., & Schiffelers, R. M. (2020) · Theranostics · doi:10.7150/thno.38147 · Cited by 373
Conferring Ti‐Based MOFs with Defects for Enhanced Sonodynamic Cancer Therapy
Liang, S., Xiao, X., Bai, L., Liu, B., Yuan, M., Ma, P., Pang, M., Cheng, Z., & Lin, J. (2021) · Advanced Materials · doi:10.1002/adma.202100333 · Cited by 359
Newly developed strategies for improving sonodynamic therapy
Wang, X., Zhong, X., Gong, F., Chao, Y., & Cheng, L. (2020) · Materials Horizons · doi:10.1039/d0mh00613k · Cited by 277
Tan, X., Huang, J., Wang, Y., He, S., Jia, L., Zhu, Y., Pu, K., Zhang, Y., & Yang, X. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102703 · Cited by 262
Improving cancer therapy through the nanomaterials-assisted alleviation of hypoxia
Sahu, A., Kwon, I., & Tae, G. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119578 · Cited by 217
Manipulation of Mitophagy by “All-in-One” nanosensitizer augments sonodynamic glioma therapy
Qu, F., Wang, P., Zhang, K., Shi, Y., Li, Y., Li, C., Lu, J., Liu, Q., & Wang, X. (2020) · Autophagy · doi:10.1080/15548627.2019.1687210 · Cited by 191
Cao, Y., Wu, T., Dai, W., Dong, H., & Zhang, X. (2019) · Chemistry of Materials · doi:10.1021/acs.chemmater.9b03430 · Cited by 189
Self-citationWang, H., Chao, Y., Liu, J., Zhu, W., Wang, G., Xu, L., & Liu, Z. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.011 · Cited by 187
Self-citationNanomaterials to relieve tumor hypoxia for enhanced photodynamic therapy
Zhang, C., Qin, W.-J., Bai, X.-F., & Zhang, X.-Z. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100960 · Cited by 180
Fu, L., Wan, Y., Li, C., Qi, C., He, T., Yang, C., Zhang, Y., Lin, J., & Huang, P. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202009848 · Cited by 167
Liu, T., Zhang, N., Wang, Z., Wu, M., Chen, Y., Ma, M., Chen, H., & Shi, J. (2017) · ACS Nano · doi:10.1021/acsnano.7b03772 · Cited by 163
Yuan, P., Mao, X., Wu, X., Liew, S. S., Li, L., & Yao, S. Q. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201901699 · Cited by 162
Breakable Hybrid Organosilica Nanocapsules for Protein Delivery
Prasetyanto, E. A., Bertucci, A., Septiadi, D., Corradini, R., Castro‐Hartmann, P., & Cola, L. D. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508288 · Cited by 157
Zheng, L., Hu, X., Wu, H., Mo, L., Xie, S., Li, J., Peng, C., Xu, S., Qiu, L., & Tan, W. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b11046 · Cited by 150
Yang, Z., Du, Y., Sun, Q., Peng, Y., Wang, R., Zhou, Y. J., Wang, Y., Zhang, C., & Qi, X. (2020) · ACS Nano · doi:10.1021/acsnano.0c02249 · Cited by 130
Jiang, T., Qiao, Y., Ruan, W., Zhang, D., Yang, Q., Wang, G., Chen, Q., Zhu, F., Yin, J., Zou, Y., et al. (2021) · Advanced Materials · doi:10.1002/adma.202104779 · Cited by 116
Broekgaarden, M., Weijer, R., Krekorian, M., van den IJssel, B., Kos, M., Alles, L. K., van Wijk, A. C. W. A., Bikádi, Z., Hazai, E., van Gulik, T. M., et al. (2016) · Nano Research · doi:10.1007/s12274-016-1059-0 · Cited by 106
Penetrating the Blood–Brain Barrier: Promise of Novel Nanoplatforms and Delivery Vehicles
Ali, I., & Chen, X. S. (2015) · ACS Nano · doi:10.1021/acsnano.5b05341 · Cited by 98
Yang, H., Hua, M., Hwang, T., Lin, K., Huang, C., Tsai, R., Ma, C.-C. M., Hsu, P., Wey, S., Hsu, P., et al. (2013) · Advanced Materials · doi:10.1002/adma.201301046 · Cited by 92
Qiao, C., Zhang, R., Wang, Y., Jia, Q., Wang, X., Yang, Z., Xue, T., Ji, R., Cui, X., & Wang, Z. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202007474 · Cited by 90
Li, J., Kong, J., Ma, S., Li, J., Mao, M., Chen, K., Chen, Z., Zhang, J., Chang, Y., Yuan, H., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100969 · Cited by 81
Cited by
Engineered exosomes from different sources for cancer-targeted therapy
Zhang, M., Hu, S., Liu, L., Dang, P., Liu, Y., Sun, Z., Qiao, B., & Wang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01382-y · Cited by 468
Self-citationStimuli responsive nanosonosensitizers for sonodynamic therapy
Jiang, Z., Xiao, W., & Fu, Q. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.08.003 · Cited by 173
Nano-ROS-generating approaches to cancer dynamic therapy: Lessons from nanoparticles
Zhang, Q., Luo, Q., Liu, Z., Sun, M., & Dong, X. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.141225 · Cited by 94
Self-citationExosomes: a promising avenue for cancer diagnosis beyond treatment
Wang, Z., Wang, Q., Qin, F., & Chen, J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1344705 · Cited by 66
Therapeutic and Diagnostic Potential of Exosomes as Drug Delivery Systems in Brain Cancer
Avgoulas, D. I., Tasioulis, K. S., Papi, R. M., & Pantazaki, A. A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051439 · Cited by 57
Metadata
- Authors
- Wu, T., Liu, Y., Cao, Y., & Liu, Z.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2022-02-27
- Volume
- 34
- Issue
- 15
- Pages
- e2110364-e2110364
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W4210920041
- Cited by
- 356
- References
- 45
- FWCI
- 21.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.